D
Derma Internacional | Buenos Aires, Argentina
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
Lebrikizumab
BMS-986165
Deucravacitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PR...
Active, not recruiting
Prurigo Nodularis
Drug: Placebo
Drug: Rocatinlimab
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Active, not recruiting
Atopic Dermatitis
Eczema
Drug: Placebo
Drug: Lebrikizumab
The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with modera...
Enrolling
Plaque Psoriasis
Drug: Deucravacitinib
Other: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems